Gates Foundation Strategic Investment Fund Logo

Inventprise LLC

Inventprise is an innovative vaccine development company based out of Redmond, Washington that is focused on developing efficacious, affordable vaccines for global populations most in need. The foundation invested in the Company to advance its novel pneumococcal conjugate vaccine (“IVT-25”). Read More


The foundation invested in Liquidia to support the application of Liquidia’s PRINT® technology to vaccine development for infectious diseases.


Affinivax achieves unprecedented levels of immune response and disease protection by streamlining the process of vaccine design and allowing for multiple antigens to be effectively incorporated in a single vaccine.